Exceptional Ventures — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
Clerkenwell Health operates specialized clinical trial sites focused on neuropsychiatric and CNS conditions, including psychedelic-assisted therapy research and trials for depression, anxiety, dementia, and neurodegenerative disorders.
BiotechDigital HealthHealthtechMedical DevicesMental HealthLondon, GB
Dr Simon G.D. Ruffell(Principal Investigator & Sub-Investigator)Dr Paul Morrison(Principal Investigator)Dr Henry Fisher(CSO)Tom McDonald(CEO)Sam Lewis(CFO)George McBride(CCO)
Co-investorsLIONHEART VENTURESMoonstone Venture Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

